Wenshuai Zheng
Rare Disease / Clinical Research
Hainan Hospital of Chinese PLA General Hospital
China.
QC-verified· April 2026 1 publication
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
Verify independently
Other specialists for Indolent B-cell non-Hodgkin lymphoma
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Mathias Rummel, DrUniversity of Giessen
- Jonathon B Cohen, MD, MS, M.DEmory UniversityGA
- Ryan Lynch, MDFred Hutch/University of Washington Cancer Consortium
- Sumithira Vasu, MD, M.DOhio State University Comprehensive Cancer CenterOH
- J Y LiThe First Affiliated Hospital of Nanjing Medical University (Department of Hematology
- L WangThe First Affiliated Hospital of Nanjing Medical University (Department of Hematology
- Xiaoning GaoThe Fifth Medical Center of Chinese PLA General Hospital
- Bo PengThe Fifth Medical Center of Chinese PLA General Hospital
See all specialists for Indolent B-cell non-Hodgkin lymphoma →